Immunovia Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 18

Employees

  • Stock Symbol
  • IMMNOV

Stock Symbol

Immunovia General Information

Description

Immunovia AB is a diagnostic company. The company develops and commercializes diagnostic tools to detect proteins and autoimmune diseases. The company is developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer. Its technology platform IMMray (TM), is based on antibody microarray analysis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Medicon Village
  • Scheelevägen 8
  • 223 81 Lund
  • Sweden
+46 046-275
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Stock Exchange
STO
Vertical(s)
Corporate Office
  • Medicon Village
  • Scheelevägen 8
  • 223 81 Lund
  • Sweden
+46 046-275

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunovia Stock Performance

As of 16-Nov-2026, Immunovia’s current market cap is $3.16M with 1.01B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.16M 1.01B 9.2M

Immunovia Financials Summary

As of 30-Sep-2026, Immunovia has a trailing 12-month revenue of $208K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,094 15,948 3,630 (14)
Revenue 208 70 88 148
EBITDA (7,716) (14,462) (9,077) (16,261)
Net Income (8,109) (14,852) (7,237) (29,112)
Total Assets 3,211 9,586 2,995 9,874
Total Debt 293 93 62 1,027
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Immunovia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunovia‘s full profile, request access.

Request a free trial

Immunovia Patents

Immunovia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4182692-A1 Methods, arrays and uses thereof Inactive 16-Jul-2020
GB-202010970-D0 Methods, arrays and uses thereof Inactive 16-Jul-2020
US-11320436-B2 Methods, arrays and uses thereof Inactive 16-Jul-2020
US-20220026431-A1 Methods, arrays and uses thereof Active 16-Jul-2020
US-20230296608-A1 Methods, arrays and uses thereof Inactive 16-Jul-2020 G01N33/57525
To view Immunovia’s complete patent history, request access »

Immunovia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunovia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Immunovia‘s full profile, request access.

Request a free trial

Immunovia ESG

Risk Overview

Risk Rating

Updated December, 31, 2022

32.18 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,766

Rank

Percentile

Healthcare

Industry

of 581

Rank

Percentile

Medical Devices

Subindustry

of 199

Rank

Percentile

To view Immunovia’s complete esg history, request access »

Immunovia FAQs

  • When was Immunovia founded?

    Immunovia was founded in 2007.

  • Where is Immunovia headquartered?

    Immunovia is headquartered in Lund, Sweden.

  • What is the size of Immunovia?

    Immunovia has 18 total employees.

  • What industry is Immunovia in?

    Immunovia’s primary industry is Diagnostic Equipment.

  • Is Immunovia a private or public company?

    Immunovia is a Public company.

  • What is Immunovia’s stock symbol?

    The ticker symbol for Immunovia is IMMNOV.

  • What is the current market cap of Immunovia?

    The current market capitalization of Immunovia is $3.16M.

  • What is Immunovia’s current revenue?

    The trailing twelve month revenue for Immunovia is $208K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process